As Shire gears up to push Vyvanse for binge eating, critics worry about abuse

Shire ($SHPG) is pushing full steam ahead to get the word out on binge eating disorder (BED), the new indication it snagged for blockbuster Vyvanse last month. But some doctors think the Dublin drugmaker may be taking its marketing a bit too far, considering the drug's abuse potential. Report